Osteovit

Quick links to important sections

Osteovit

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Osteovit

Quick Facts: Osteovit Identity

Property Description
Active Ingredients Calcium Citrate, Colecalciferol (Vitamin D3)
Form Oral Tablet or Capsule
Pharmacological Class Vitamin and Mineral Combination
General Purpose Support for Skeletal Integrity and Bone Health
Origin Derived (Nutritional Supplement)

Osteovit: What Type of Combination Supplement Is It?

Osteovit is fundamentally a combination product belonging to the Vitamin and Mineral Combination pharmacological class, consisting of the two essential active ingredients: Calcium Citrate and Colecalciferol (Vitamin D3). It is typically delivered as an Oral Tablet or Capsule for oral consumption. The combined use of both mineral and vitamin is recognized for its synergistic effect in supporting bone structure. This product is often positioned for comprehensive nutritional support in patient groups such as adults, adolescents, and post-menopausal women.

Composition Breakdown: Why Calcium Citrate and Vitamin D3?

The specific composition of Osteovit utilizes the mineral salt Calcium Citrate, paired with Colecalciferol. The selection of the citrate salt is a primary differentiating factor compared to formulations using calcium carbonate, as the citrate form is recognized for its high bioavailability and is often noted for being gentler on the digestive system. Colecalciferol is the official term for Vitamin D3, which the body classifies as a prohormone. This intentional pairing ensures that the Vitamin D component actively regulates the utilization and effective absorption of the mineral, addressing both supply and demand.

General Purpose: What Does Osteovit Support?

The overall general purpose of Osteovit is to provide foundational nutritional support for bone health and skeletal integrity. The core action is to promote efficient calcium absorption and subsequent bone mineralisation, which is crucial for maintaining the body’s structural framework. Adequate vitamin D intake is critical for bone health by helping the body effectively use calcium. This dual-action mechanism confirms its role as a prophylactic agent in scenarios where dietary intake or exposure may be insufficient, supporting long-term bone mass and stability.

Regulatory References

  1. Overview of Vitamin D
  2. Vitamin D Fact Sheet for Consumers

What side effects are possible with Osteovit?

Possible Side Effects and Safety Information

Adverse Reaction Scope

The official safety profile for Osteovit, a combination of Calcium Citrate and Colecalciferol (Vitamin D3), is primarily structured around the potential for mineral over-accumulation, as documented by regulatory bodies. Adverse reactions are classified by the physiological systems they affect, with the main focus on Gastrointestinal and Metabolism and Nutrition Disorders.

Common adverse reactions typically involve gastrointestinal symptoms such as constipation, flatulence, nausea, and abdominal pain.

Serious Adverse Reactions and Safety Restrictions

The most serious officially documented risks include Hypercalcemia (excessive calcium levels in the blood), Nephrolithiasis (kidney stones), and signs of Hypervitaminosis D (Vitamin D toxicity). These risks are particularly associated with long-term use or prolonged high-dose exposure, according to official regulatory notes.

Classification Examples of Reactions
Gastrointestinal Disorders Constipation, Nausea, Abdominal Pain
Metabolism Disorders Hypercalcemia, Hypercalciuria
Renal Disorders Nephrolithiasis (Kidney Stones)

Population-Specific Safety

Official labeling explicitly addresses safety considerations for specific populations. The product is contraindicated in patients with pre-existing Hypercalcemia or Hypervitaminosis D. Patients with Renal Impairment require caution and potential monitoring, as they have an increased risk of elevated calcium levels. Furthermore, official government health bodies specify strict upper intake limits for the Pediatric Population, and note that high doses are possibly unsafe during Pregnancy and Lactation.

Regulatory Safety Summary

The regulatory safety structure emphasizes that while minor gastrointestinal discomfort is common, the core safety focus is on managing the risk of serious, dose- and duration-dependent systemic mineral accumulation, which dictates the explicit contraindications and safety restrictions.

Overdose and Emergency Response

Overdose and when to seek help

Overdosage with Osteovit (Calcium Citrate and Colecalciferol) is officially defined by the effects of mineral and vitamin excess, primarily hypercalcaemia and hypervitaminosis D. This information is strictly based on government regulatory documentation.


Category Official Regulatory Documentation
Documented Overdose Presentations Overdose is characterized by the effects of hypercalcaemia and hypervitaminosis D. Documented symptoms often include nausea, vomiting, anorexia (loss of appetite), polyuria (excessive urination), polydipsia (excessive thirst), fatigue, and later, mental disturbances.
Serious/Life-Threatening Outcomes The risks associated with severe or prolonged toxicity include irreversible renal impairment (nephrocalcinosis), cardiac arrhythmias, and generalized vascular calcification. Extreme hypercalcaemia may lead to coma or death.
Emergency-Response Statements The product must be stopped immediately upon suspicion of overdosage. Management involves rehydration and supportive procedures, which may include administering diuretics or bisphosphonates. No specific antidote is known.
When Immediate Medical Help is Required Seek emergency medical attention or call emergency services immediately if severe symptoms occur, such as passing out, trouble breathing, or being unable to be awakened, as stated in official guidance.

The official overdose profile is strictly defined by the documented systemic manifestations of mineral and vitamin excess, such as gastrointestinal distress and laboratory-confirmed hypercalcaemia. Regulatory guidance focuses on the risks of severe or irreversible organ damage to the renal and cardiovascular systems. The mandated emergency protocol requires immediate cessation of the product and urgent medical attention when severe toxicity is suspected, alongside specific supportive procedures and monitoring requirements.

Therapeutic Uses of Osteovit

What Osteovit Treats: Main Uses and Benefits

Osteovit is generally used to provide supportive management in clinical settings that involve acute or unstable symptom patterns linked to deficiency. Its use is relevant across domains where short-term symptom management for nutritional imbalance is appropriate, and it assists with maintaining functional stability.

The therapeutic domains considered relevant include assistance with acute discomfort, support for functional stability, and application across conditions characterized by episodic or fluctuating manifestations. Osteovit may be applied in situations involving certain distressing symptoms, particularly those related to systemic imbalance and physical discomfort. It may assist with addressing symptom clusters that may become intense or disruptive, contributing to comfort during symptomatic periods.

“This supportive management may help patients cope more steadily with symptom fluctuations.”

Quick Fact: Supports in Managing Physical Discomfort


Managing Acute Symptomatic Discomfort

Osteovit is considered relevant across conditions involving episodic or fluctuating manifestations linked to physiological strain. It contributes to easing discomfort during periods of heightened symptoms.


Support for Functional Stability

Osteovit may be used in situations where functional stability becomes affected, assisting with maintaining functional stability and contributing to easing the overall symptom load.

Regulatory References

  1. Therapeutic Goods Administration (TGA) of Australia

Eligibility and Restrictions for Use

Who Can and Cannot Use Osteovit? — Official Regulatory Information

The eligibility for using Osteovit (Calcium Citrate and Colecalciferol combination) is strictly defined by regulatory documents based on existing metabolic conditions, kidney function, and age.

Contraindications: Populations Who Must Not Use Osteovit

The medicine is absolutely contraindicated in individuals with:

  • Hypercalcaemia (high calcium levels in the blood).
  • Hypercalciuria (high calcium levels in the urine).
  • Hypervitaminosis D (excessively high Vitamin D levels).
  • A known hypersensitivity to the active ingredients or excipients.
  • Severe Renal Impairment or a history of Nephrolithiasis (kidney stones).

Age and Conditional Use Restrictions

Official labels designate Adults and the Elderly as target populations, particularly those with deficiency risks. The medicine is generally not recommended for children under 12 years of age due to the Vitamin D component strength. Use during pregnancy and lactation is dose-dependent, and high-dose formulations are typically not indicated.

Use requires caution and close monitoring for patients with Mild to Moderate Renal Impairment, Sarcoidosis, or conditions causing malabsorption, as these conditions may alter calcium metabolism.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Osteovit, typically containing Calcium and Vitamin D (Cholecalciferol), can interact with several medicinal products and certain foods, primarily by altering absorption or increasing the risk of high calcium levels (hypercalcaemia).

Interactions affecting absorption or metabolism:

  • Systemic Corticosteroids may decrease the body's absorption of calcium.
  • Fat absorption inhibitors (e.g., Orlistat, bile acid sequestrants like Cholestyramine, or mineral oil) can impair the absorption of the fat-soluble Vitamin D component.
  • Certain Anticonvulsants (e.g., Phenytoin, Phenobarbital) and Rifampicin can increase the breakdown of Vitamin D, potentially reducing its effect.
  • Foods high in oxalic acid (e.g., spinach, rhubarb) or phytic acid (e.g., whole grains) may reduce calcium absorption; it is advisable to separate the product's administration from consuming these foods.

Interactions increasing toxicity risk:

  • Cardiac Glycosides (e.g., Digoxin) effects may be accentuated by co-administration due to increased risk of hypercalcaemia, requiring strict monitoring of the heart rhythm (ECG) and blood calcium levels.
  • Thiazide Diuretics can decrease calcium excretion in the urine, and when combined with Vitamin D, significantly raise the risk of hypercalcaemia.
  • Concomitant use of other Vitamin D compounds or phosphate supplements should be avoided due to the additive risk of hypercalcaemia and/or hyperphosphataemia.

Mechanism of Action

Vitamin D Receptor-Mediated Gene Regulation

Osteovit's core active component, Vitamin D, is converted into the steroid hormone calcitriol left(1,25(mathrmOH)2 mathrmD3 ight) within the body. Calcitriol functions as a high-affinity ligand for the Vitamin D Receptor (VDR), a nuclear receptor and transcription factor. This ligand-receptor complex translocates to the nucleus and regulates the transcription of numerous genes by binding to specific Vitamin D Response Elements (VDREs), thereby modifying early molecular steps that shape systemic physiological outcomes.


Intestinal Absorption and Systemic Kinetic Modulation

A key pathway effect involves calcitriol facilitating the active transport of dietary calcium and phosphorus across the intestinal epithelium, directly influencing their serum concentrations. Furthermore, the active compound engages mechanisms that influence feedback regulation within the parathyroid and renal pathways. Calcitriol promotes the renal reabsorption of calcium and, when necessary, mobilizes calcium and phosphate from the bone matrix. This coordinated action influences the feedback loop involving parathyroid hormone (PTH) and ultimately results in a modulation of calcium and phosphate kinetic equilibrium.

Dosage and Administration Information

How to Use Osteovit — Official Administration Guidelines

The usage of Osteovit, a combination product containing Calcium Citrate and Colecalciferol (Vitamin D3), is defined by a standardized administration protocol to optimize absorption and safety.


Administration Scope

Field Detail
Route of administration Oral ingestion. Forms include tablets, capsules, liquids, and chewable tablets.
Dosing schedule Maintenance dosing typically ranges from 600 mg to 1200 mg of elemental calcium daily, combined with 400 IU to 1000 IU of Vitamin D3 daily.
Timing in relation to meals The medicine is generally administered with food to facilitate the absorption of the fat-soluble Colecalciferol component.
Preparation requirements Chewable dosage forms must be chewed or crushed before swallowing.
Age-group rules Dosing for older adults (typically 70 years) may specify the higher range of Vitamin D3 intake, often between 800 IU and 1000 IU per day.
Missed-dose rules If a dose is missed, the subsequent dose should not be doubled to compensate for the omission.
Special procedural conditions The medicine must not exceed the recommended daily dosage. Use in once-daily regimens is generally not recommended for patients with severe renal impairment.

Resulting Procedural Structure

Standard instructions establish the use of Osteovit as a long-term maintenance plan, although a short-term course may be utilized for initial correction of a deficiency. The frequency pattern is typically daily (once or twice) for the combination product, but weekly options exist for high-dose Colecalciferol-only formulations. This structure defines the precise quantity, rhythm, and context of intake, ensuring adherence to the intended use protocol.

Recent Clinical Evidence

Osteovit: Recent Clinical Evidence

Clinical research on Osteovit (a modified vitamin D agent) focuses primarily on its role in calcium homeostasis and metabolism, essential functions for bone health. Studies indicate that the agent is converted in the liver and kidneys to an active form that binds to the Vitamin D Receptor (VDR). This process is thought to regulate the absorption of calcium and phosphate in the small intestine, which is vital for bone mineralization.

Clinical Trial Findings

Overall, randomized controlled trials (RCTs) and observational studies have evaluated whether Osteovit is associated with changes in measures of bone mineral density and reduced risk markers for certain bone conditions, such as osteomalacia and rickets. Findings suggest that maintaining adequate serum levels of the active metabolite (25-hydroxyvitamin D) may be a key factor in musculoskeletal health.

  • Primary Indication Evidence: Large-scale epidemiological data and subsequent RCTs have examined the relationship between supplementation and skeletal outcomes in specific adult populations. These studies primarily assess whether the intervention is associated with changes in bone density measurements over extended periods.
  • Secondary Use Exploration: Researchers have also explored whether the agent is associated with outcomes in non-skeletal processes, such as aspects of the immune system. Evidence remains limited in these areas, and conclusive results are not yet established.

Safety Profile and Pharmacokinetics

Studies report that the agent is metabolized primarily by the CYP450 enzyme system, which is a factor considered during dosage and co-administration research. Adverse event reporting in pharmacovigilance studies has primarily focused on the risks associated with high concentrations of vitamin D metabolites. The most commonly reported serious adverse events include hypercalcemia (high calcium levels) and, less frequently, renal impairment. These events are often correlated with higher doses or co-administration with other products.

Key Studies & References

  1. Dietary Reference Intakes for Calcium and Vitamin D: Report of the Food and Nutrition Board, Institute of Medicine (IOM)

Frequently Asked Questions (FAQ)

Common questions about Osteovit (FAQ)


Q: Is Osteovit the same as a regular vitamin supplement?

A: Official information defines Osteovit as a combination product belonging to the Vitamin and Mineral Combination class. It contains two distinct active ingredients: Calcium Citrate (a mineral salt) and Colecalciferol (Vitamin D3), which is classified as a prohormone. This dual composition is specifically structured for its combined effect on bone health and mineral balance.


Q: What is the difference between Osteovit and [Name of similar supplement]?

A: Regulatory documents define Osteovit based on its specific composition, which includes Calcium Citrate and Colecalciferol (Vitamin D3). The specific choice of the citrate salt is supported by pharmacological studies for its bioavailability and absorption properties, which is one distinguishing factor from formulations using different calcium salts.


Q: What is the importance of the specific ingredient in Osteovit?

A: The formulation utilizes the salt form Calcium Citrate. This specific choice is pharmacologically supported because the citrate form is highly bioavailable and its absorption is often noted as being less dependent on the acidity level within the stomach compared to other calcium salts.


Q: Why do I see different strengths of Osteovit online?

A: Official drug documents from regulatory bodies list that Osteovit is provided in multiple different dosage forms (e.g., tablets, capsules) and strengths. This is intended to allow for a range of required daily intakes for elemental calcium and Vitamin D3, as defined in standardized dosing protocols.


Q: How quickly does Osteovit start to work or show effects?

A: Official product information describes the component actions as supporting calcium homeostasis (mineral balance) and bone mineralization, which are typically long-term physiological processes. The intended effects are usually assessed in studies over extended periods and should not be expected to occur immediately after a single use.


Q: Is Osteovit intended for daily or occasional use?

A: The standardized administration protocol is generally structured as a long-term maintenance plan for nutritional support, with frequency patterns typically being daily. However, a short-term course may also be utilized by healthcare professionals, for instance, for the initial correction of a mineral deficiency.


Q: How long can a person safely stay on Osteovit?

A: Official documents describe the use of Osteovit as a long-term maintenance plan when medically appropriate. Warnings emphasize that the core risks, such as high blood calcium (hypercalcemia) and kidney stones, are associated with prolonged, long-term use, which is a key reason why medical monitoring is usually recommended during use.


Q: Are the effects of Osteovit permanent after stopping use?

A: Osteovit helps to support the body’s calcium and phosphate kinetic equilibrium (balance of minerals). Since the maintenance of this mineral balance requires ongoing physiological input, the continued stability of mineral levels generally relies on adequate dietary intake or continued supplementation.


Q: Does Osteovit help with joint pain or is it just for bones?

A: The official therapeutic indication for Osteovit is defined as providing nutritional support for skeletal integrity and bone health by regulating calcium and phosphorus metabolism. Official regulatory documents generally describe the product's purpose for bone health and do not typically include joint pain outcomes.


Q: Does Osteovit cause weight gain or weight loss?

A: Weight changes are not commonly listed or specifically identified in the official safety profile of Osteovit. The most commonly reported issues involve the digestive system (like constipation) or high blood calcium levels, which can sometimes be associated with a reduced appetite.


Q: Is it normal to feel fatigued when starting Osteovit?

A: Fatigue is not listed among the common adverse reactions in the official safety profile for Osteovit. The most commonly reported issues are related to the gastrointestinal system or excessive mineral accumulation. For specific concerns, official safety sources should be reviewed.


Q: Can Osteovit be taken with pain relievers like ibuprofen or aspirin?

A: Official drug interaction lists specify products that can alter absorption or increase the risk of high calcium levels, such as corticosteroids and certain diuretics. Ibuprofen or aspirin are not commonly named in official regulatory warnings for this combination product type.


Q: Can Osteovit interact with my thyroid medication?

A: Regulatory documents note that calcium-containing products may decrease the absorption of certain medicines, such as levothyroxine (a common thyroid hormone). Official documents indicate that separating the administration times by a specified number of hours is generally considered to manage this potential interaction.


Q: Does Osteovit interact with common herbal supplements?

A: Official regulatory warnings generally do not list every herbal product. However, official sources advise that the use of other Vitamin D compounds or calcium supplements should be avoided due to the additive risk of excessive mineral accumulation in the body.


Q: Does taking Osteovit influence the absorption of other nutrients?

A: Yes, regulatory documents indicate that the calcium component may affect the absorption of certain medicinal compounds, such as some antibiotics (tetracyclines) and thyroid hormones. Separation of administration times is generally discussed with a healthcare professional to manage this potential effect.


Q: Does Osteovit affect blood sugar levels?

A: While the active components are involved in many bodily functions, including those that influence insulin, effects on blood sugar or glucose are not a commonly cited adverse reaction or drug interaction in the official regulatory product labeling.


Q: Can I use Osteovit if I have an allergy to certain minerals?

A: Official labeling explicitly lists a known hypersensitivity to the active ingredients (Calcium Citrate, Colecalciferol) or the other components of the product as a contraindication for its use.


Q: Is Osteovit safe for teenagers or young adults?

A: Official labels typically designate Adults and the Elderly as the primary target populations. The medicine is usually not recommended for children under 12 years of age. Use in adolescents is sometimes mentioned, generally under specific medical direction.


Q: Why is Osteovit often recommended alongside [Name of another common medicine]?

A: Osteovit is commonly used as a nutritional adjunct because its primary function is to optimize calcium and vitamin D levels. Maintaining adequate levels of these minerals is often recommended in treatment guidelines when patients are taking other medications that address bone loss or mineral balance.


Q: What happens if I stop taking Osteovit suddenly?

A: Stopping a long-term maintenance plan can lead to a gradual reduction in the body's stored mineral levels over time, especially if dietary intake is insufficient. Official documents do not typically describe any acute or immediate withdrawal effects.


Q: What types of tests might a doctor order before starting Osteovit?

A: Due to the risk of high blood calcium (hypercalcemia), official warnings recommend that patients receive periodic monitoring of serum and urinary calcium levels. Additionally, a person’s renal function is often checked, especially during high-dose or long-term administration.


Q: Does Osteovit help to prevent bone fractures?

A: Regulatory studies and evidence primarily assess Osteovit's association with improvements in bone mineral density and the reduction of risk markers for certain bone conditions. Official claims are typically restricted to bone health support and mineral homeostasis.


Q: Does official research cover the use of Osteovit in ethnic populations?

A: Clinical literature acknowledges that factors like skin pigmentation can influence the body’s natural synthesis of Vitamin D, leading to acknowledged differences in Vitamin D levels across various populations. Research themes have explored these differences and their implications for bone health.

How should Osteovit be stored and disposed of?

Osteovit must be stored under specific conditions to maintain its labeled potency and stability. The medicine should be kept at Controlled Room Temperature, away from excess heat, and it is explicitly stated that the product must not be frozen. Storage areas should be dry; the product must be protected from both light and moisture, and storing it in a bathroom is discouraged.

For container requirements, Osteovit must remain in its original container, which should be kept tightly closed to preserve its integrity. For safety, the product must be stored out of the sight and reach of children.

Expired or unused Osteovit should not be flushed down the toilet or placed in household trash. Disposal should follow local regulations, ideally through a drug take-back program or by consulting a pharmacist for guidance on safe discarding procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Osteovit found in:

A-Z Index: